A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

SOUTH SAN FRANCISCO, Calif. - Vistagen Therapeutics (VTGN), a clinical-stage biopharmaceutical company with a market ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

"This medication — which is a drug that inhibits sodium channels — works outside the brain on pain receptors," she noted. "To have a non-opioid option to prescribe in these cases is exciting ...